120
Participants
Start Date
November 24, 2019
Primary Completion Date
May 24, 2021
Study Completion Date
October 24, 2022
Entecavir 0.5 mg
Orally administered Entecavir 0.5 mg, once a day. For six months
A 10-g packet of lactulose oral solution and three capsules of probiotics
"A 10-g packet of lactulose oral solution and three capsules of probiotics (each containing \> 4.2×106 CFU Clostridium butyricum and \> 4.2×105 CFU Bifidobacterium longum infantis).~Participants orally administered the contents three times daily after meals. For six months."
A 10-g packet of glucose oral solution and three capsules of starch
A 10-g packet of glucose oral solution and three capsules of starch. Participants orally administered the contents three times daily after meals. For six months.
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
First Affiliated Hospital of Zhejiang University
OTHER